Entity usage
From MaRDI portal
This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.
Showing below up to 1 result in range #1 to #1.
- Optimal two-stage designs for phase ii clinical trials with differentiation of complete and partial responses: Some statements, Label: en, Miscellaneous (e.g. aliases, entity existence), Sitelink, Title